131 0 Kommentare Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors

PLEASANTON, Calif., March 20, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced the appointment of Ilan Daskal, current Chief Financial Officer & Executive Vice President of Bio-RAD Laboratories, to its board of directors and audit committee effective March 19, 2020. The Company will also nominate Mr. Daskal at its 2020 Annual Meeting of Stockholders.

“We are pleased to welcome Ilan as a new independent director to the Natus board,” said Barbara R. Paul, M.D., Chairperson of Natus' board of directors. “Ilan's extensive financial and operational experience complement our current board members, strengthening the board and company as we focus on driving value for our customers, employees and stockholders.” The Natus board is committed to regular evaluation of its composition, to refreshment and to building a board with a mix of skills, expertise and experience that supports stockholder value creation.

Natus’ other directors consist of Barbara R. Paul, M.D., former Chief Medical Officer of Community Health Systems, Joshua Levine, President and CEO of Accuray, Incorporated, Kenneth Ludlum, former CFO of CareDx, Inc., Lisa Wipperman Heine, President & CEO of PreCardia, Inc., Alice D. Schroeder, former CEO and Chair of WebTuner Corporation, Thomas J. Sullivan, President and CEO of A&E Medical Corporation, and Jonathan Kennedy, President and CEO of the Company.

Kenneth Ludlum has advised the board that he will not stand for re-election at the 2020 Annual Meeting of Stockholders. Mr. Ludlum has served on the Natus board of directors and as Chairman of the Audit Committee since 2002. We thank him for his service and the contributions he has made to the success and growth of the Company over his 18-year tenure. Following Mr. Ludlum’s retirement, the Natus board will be composed of seven directors.

About Ilan Daskal

Currently, Ilan Daskal holds the position of Executive Vice President and Chief Financial Officer of Bio-Rad Laboratories, Inc.

Over his career Mr. Daskal has held numerous senior financial roles and CFO positions at both public and private companies that include Lumileds, International Rectifier Corporation and Infineon. Mr. Daskal also served on the Board of Directors of Ixia.